AMG-706 Comparison To Avastin Is Critical To Commercial Success, Amgen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen reiterates need to compare the investigational oncologic to Avastin after changing its Phase III clinical program in April.